König et al. obtained the plasma samples from breast cancer patients before and after neoadjuvant chemotherapy; the samples were quantified for total soluble HLA-G (sHLA-G) and HLA-G levels by ELISA. This evidence concerns the gene HLA-G and breast carcinoma.